A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. (Q50709215)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. |
scientific article published in November 2006 |
Statements
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug (English)
Astrid Mayer
Surinder K Sharma
Berend Tolner
Jan Martin
Geoff M Boxer
James Bell
Alan J Green
John A Hartley
Clare Cruickshank
Julie Wren
Kerry A Chester
Richard H J Begent
1 November 2006